Jananom, a company specializing in synthetic biology services and products, is excited to announce its plans to advance three specialty chemical strains to the next level of process development this year. The company's team of experienced scientists, who have previously successfully scaled up various groundbreaking and unprecedented molecules, will lead this initiative.”, said Dr. Murali Panchapagesa Muthuswamy, the founder of Jananom. Jananom is granted US Patent no. US 11,898,183 B2 dated February 13, 2024 in the area of living medicines.

Jananom is ABLE's Gold member company.